Empagliflozin Eyed for Outpatient Chronic Hyponatremia

The SGLT2 inhibitor increased sodium and reduced neurocognitive dysfunction in patients with chronic hyponatremia due to the syndrome of inappropriate antidiuresis.
Medscape Medical News

Leave a Reply

Your email address will not be published.